**Core Concept**
Lupus anticoagulant is a type of autoantibody that interferes with the coagulation cascade, increasing the risk of thrombosis. It is often associated with antiphospholipid syndrome (APS), an autoimmune disorder characterized by recurrent thrombotic events.

**Why the Correct Answer is Right**
Option A is incorrect because lupus anticoagulant is actually associated with an increased risk of thrombosis, not bleeding episodes. The name "lupus anticoagulant" is a misnomer, as it does not increase the risk of bleeding but rather prolongs coagulation assays due to its interference with phospholipid-dependent coagulation pathways. The correct association is with an increased risk of thrombotic events, which can be life-threatening.

**Why Each Wrong Option is Incorrect**
**Option B:** This statement is true. Lupus anticoagulant can prolong activated partial thromboplastin time (aPTT), a coagulation assay used to evaluate the integrity of the intrinsic coagulation pathway.

**Option C:** This statement is true. Lupus anticoagulant can occur without clinical signs, and its presence may be detected incidentally during routine coagulation testing.

**Option D:** This statement is true. Lupus anticoagulant is associated with recurrent miscarriages, particularly in the mid-trimester, due to its contribution to the pathogenesis of APS.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the presence of lupus anticoagulant can be a diagnostic clue for APS, which requires a comprehensive evaluation, including clinical history, laboratory tests, and imaging studies.

**✓ Correct Answer:** A. Bleeding episodes can be life threatening